NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
15/10/2024
Voltar para busca
Dado oficial do USPTO
A.I.R
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
A.I.R
ST13
US500000087024815Classe
1, 5, 16, 42, 44
Pedido
87024815
Registro
6481284
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
15/10/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 16, 42, 44
Data de depósito
04/05/2016
Data de registro
14/09/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/09/2021
Última transação
28/02/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
94
Localização do titular
Mainz, DE
Examinador
GAGLIARDI, JEANINE
Localização atual
Historical data usage
Titulares e representantes
Titulares
B. S. (pessoa física)
B. S. (pessoa física)
BioNTech RNA Pharmaceuticals GmbH
Representantes
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 16Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Active chemical ingredients for use in manufacture of anti-cancer drugs and vaccinesin particular nucleic acidsamplifying nucleic acidspeptides and proteins for laboratory use
Classe 5
Human and veterinary pharmaceutical preparationsin particular for the prevention and treatment of cancerinfectious diseasesimmunological diseasesin particular by way of nucleic acidsamplifying nucleic acidsvirusesviral like particlespeptides and proteins
Classe 16
Pharmaceutical and veterinary information leaflets; Printed pamphletsbrochuresmanualsbooksbookletsleafletsflyersinformational sheets and newsletters for providing medicalpharmaceuticalscientific research information
Classe 42
Providing scientific research informationconsultancyadvisory servicesmedical research informationconsultancyadvisory servicesin particular in the fields of treatment and prevention of immunological diseasescancer treatmentprevention of cancertreatment of infectious diseasesprevention of infectious diseases for humans or animals; Providing medical research informationconsultancyadvisory servicesin particular in the fields of treatment and prevention of immunological diseasescancer treatmentprevention of cancertreatment of infectious diseasesprevention of infectious diseases
Classe 44
Medical servicesin particularproviding therapies and vaccination approaches for treating and preventing cancerinfectious diseases and immunological diseases; Veterinary servicesin particularproviding therapies and vaccination approaches for treating and preventing cancerinfectious diseasesimmunological diseases; Medicalveterinary and pharmaceutical consultation; Medical and veterinary diagnostic testingmonitoring and reporting services
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
06/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/09/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
28/02/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/02/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
22/02/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/02/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/02/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22/02/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
22/02/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/10/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
14/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/06/2021
PUBO
PUBLISHED FOR OPPOSITION
29/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/04/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
23/04/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
27/01/2021
GNSL
LETTER OF SUSPENSION E-MAILED
27/01/2021
CNSL
SUSPENSION LETTER WRITTEN
27/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2021
ALIE
ASSIGNED TO LIE
29/12/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
23/12/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/07/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/12/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
28/05/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/11/2018
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/05/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
23/10/2017
GNSL
LETTER OF SUSPENSION E-MAILED
23/10/2017
CNSL
SUSPENSION LETTER WRITTEN
23/10/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/10/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
31/03/2017
GNRT
NON-FINAL ACTION E-MAILED
31/03/2017
CNRT
NON-FINAL ACTION WRITTEN
31/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/03/2017
ALIE
ASSIGNED TO LIE
13/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/02/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/08/2016
GNRT
NON-FINAL ACTION E-MAILED
26/08/2016
CNRT
NON-FINAL ACTION WRITTEN
26/08/2016
DOCK
ASSIGNED TO EXAMINER
19/08/2016
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
21/07/2016
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
21/07/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/05/2016
NWAP
NEW APPLICATION ENTERED
07/05/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace A.I.R ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.